Mesenchymal Stem Cells Market to Grow with a CAGR of 8.54% through 2030F
Rising prevalence of chronic diseases and the
increasing investment in biotechnology are factors driving the global
Mesenchymal Stem Cells market in the forecast period 2026-2030F
According to TechSci Research report, “Mesenchymal Stem Cells Market – Global
Industry Size, Share, Trends, Competition Forecast & Opportunities,
2030F”, the Global Mesenchymal Stem Cells Market stood at USD 2.71 billion in
2024 and is anticipated to grow with a CAGR of 8.54% in the forecast period. The global Mesenchymal Stem Cells (MSCs) market has been
experiencing significant growth in recent years, driven by a combination of
factors that underscore the importance of regenerative medicine and cell-based
therapies. MSCs are multipotent adult stem cells with the ability to
differentiate into various cell types, making them a valuable resource in the
field of regenerative medicine.
The global population is aging at an unprecedented rate, leading to a surge in
age-related diseases and conditions such as osteoarthritis, Alzheimer's
disease, and heart disease. MSC-based therapies hold immense potential for
addressing age-related health issues by promoting tissue repair and
regeneration. As the elderly population continues to grow, the demand for
MSC-based treatments is expected to rise substantially.
One of the primary drivers of the global MSCs market is the increasing prevalence of chronic diseases, including cardiovascular disorders, diabetes, orthopedic conditions, and autoimmune diseases. MSC-based therapies offer the potential to treat these diseases effectively. The regenerative capabilities of MSCs can help repair damaged tissues and modulate the immune system, making them a promising tool for addressing the growing burden of chronic illnesses.
The global population is aging at an unprecedented rate, leading to a surge in age-related diseases and conditions such as osteoarthritis, Alzheimer's disease, and heart disease. MSC-based therapies hold immense potential for addressing age-related health issues by promoting tissue repair and regeneration. As the elderly population continues to grow, the demand for MSC-based treatments is expected to rise substantially.
Advancements in cell therapy research have propelled the development of innovative MSC-based treatments. Researchers are continuously uncovering new applications for MSCs, such as tissue engineering, wound healing, and immunomodulation. These breakthroughs have expanded the market's potential, as pharmaceutical companies and biotechnology firms invest in the development of novel therapies that harness the therapeutic potential of MSCs.
Collaborations between academic institutions, research organizations, and pharmaceutical companies have become more common in the field of regenerative medicine. These partnerships facilitate the exchange of knowledge, expertise, and resources, leading to accelerated research and development efforts. Collaborative initiatives are vital drivers of innovation and market growth in the MSCs sector.
The Global Mesenchymal Stem Cells Market is segmented into product &
services, workflow, type, source of isolation, indication, application, region and
company.
Based on source of isolation, bone marrow was the dominant
source in the global mesenchymal stem cell (MSC) market. This is primarily due
to its long-established clinical use, high concentration of MSCs, and extensive
research supporting its efficacy and safety in regenerative therapies. Bone
marrow-derived MSCs have been widely studied and applied in treating
orthopedic, autoimmune, and neurodegenerative disorders. Their
well-characterized profile, strong clinical data, and regulatory familiarity
contribute to their leadership in the market.The established harvesting
techniques and widespread infrastructure in hospitals and research institutions
further support bone marrow’s continued dominance over newer or
less-characterized MSC sources like adipose tissue or cord blood.
Based on region, Asia-Pacific is the fastest-growing region in the global
mesenchymal stem cell (MSC) market due to a combination of supportive
government initiatives, increasing healthcare investments, and rising demand
for regenerative medicine. Countries like China, Japan, South Korea, and India
are actively investing in stem cell research and clinical trials. The region
also benefits from a large patient population, lower manufacturing costs, and
expanding biotechnology sectors. The favorable regulatory reforms and
collaborations between academic institutions and biotech firms are accelerating
innovation. These factors collectively drive rapid adoption and development of
MSC-based therapies, positioning Asia-Pacific as a key hub for market
expansion.
Major companies operating in Global Mesenchymal Stem
Cells Market are:
· Thermo
Fisher Scientific, Inc
· Cell
Applications, Inc
· Axol
Biosciences Ltd
· Cytori
Therapeutics Inc
· STEMCELL
Technologies
· Cyagen
Biosciences
· Celprogen
Inc
· BrainStorm
Cell Limited
· Stemedica
Cell Technologies Inc
· Merck
KGaA (MilliporeSigma)
· PromoCell
GmbH
Customers can also request 10% free customization on this
report.
“The global Mesenchymal Stem Cells market is poised for substantial growth in
the coming years, thanks to a convergence of key market drivers. The rising
prevalence of chronic diseases, the aging population, advances in cell therapy
research, regulatory support, increasing investments in biotechnology, rising
patient awareness, and collaborative partnerships are all contributing to the
expansion of this dynamic market. As the therapeutic potential of MSCs
continues to be explored and realized, we can expect further advancements and
breakthroughs in the field of regenerative medicine, with significant benefits
for patients worldwide”, said Mr. Karan Chechi, Research Director with TechSci
Research, a research-based management consulting firm.
“Mesenchymal Stem Cells Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product & Services (Products(Cells &
Cell Lines, Kits, Media, & Reagents, Others), Services), By Workflow
(Cell Sourcing & Isolation, Culture & Cryopreservation,
Differentiation, Characterization), By Type ( Autologous, Allogeneic), By
Source of Isolation( Bone Marrow, Cord Blood, Peripheral Blood, Fallopian Tube,
Fetal Liver, Lung, Adipose Tissues), By Indication (Bone And Cartilage Repair,
Cardiovascular Disease, Inflammatory And Immunological Diseases, Liver
Diseases, Cancer, GvHD, Others), By Application ( Disease Modelling, Drug
Development & Discovery, Stem Cell Banking, Tissue Engineering, Toxicology
Studies, Others), By Region & Competition, 2020-2030F”, has evaluated the
future growth potential of Global Mesenchymal Stem Cells Market and provides
statistics & information on market size, structure and future market
growth. The report intends to provide cutting-edge market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Mesenchymal Stem Cells Market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com